The International Transporter Consortium: A Collaborative Group of Scientists From Academia, Industry, and the FDA

被引：56
作者：
Huang, S-M [2 ]
Zhang, L. [2 ]
Giacomini, K. M. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[2] US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷 / 01期
关键词：
DRUG-DRUG INTERACTIONS; EFFLUX TRANSPORTERS; KIDNEY; IMPACT; LIVER; OATP;
D O I：
10.1038/clpt.2009.236
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The US Food and Drug Administration-led Critical Path Initiative, launched in 2004, has resulted in an array of activities focused on the sciences that support the development of human medical products.(1) These activities include the development of new scientific tools, such as in vitro testing, qualified biomarkers of drug safety, and innovative new methods in study design and data analysis.(2) As a result of the Critical Path Initiative and enormous advances in the field of membrane transporters, the International Transporter Consortium was formed.
引用
收藏
页码：32 / 36
页数：5
相关论文
共 15 条
  • [1] Medical product development and regulatory science for the 21st century: The critical path vision and its impact on health care
    Buckman, S.
    Huang, S-M
    Murphy, S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) : 141 - 144
  • [2] ABC Pumps and Their Role in Active Drug Transport
    Colabufo, Nicola A.
    Berardi, Francesco
    Contino, Marialessandra
    Niso, Mauro
    Perrone, Roberto
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (02) : 119 - 129
  • [3] Novobiocin Is a Potent Inhibitor for Human Organic Anion Transporters
    Duan, Peng
    You, Guofeng
    [J]. DRUG METABOLISM AND DISPOSITION, 2009, 37 (06) : 1203 - 1210
  • [4] The role of hepatic transporters in drug elimination
    Funk, Christoph
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (04) : 363 - 379
  • [5] GIACOMINI KM, 2006, PHARMACOL BASIS THER, P41
  • [6] Intestinal drug transporter expression and the impact of grapefruit juice in humans
    Glaeser, H.
    Bailey, D. G.
    Dresser, G. K.
    Gregor, J. C.
    Schwarz, U. I.
    McGrath, J. S.
    Jolicoeur, E.
    Lee, W.
    Leake, B. F.
    Tirona, R. G.
    Kim, R. B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (03) : 362 - 370
  • [7] Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays
    Hegedus, Csilla
    Szakacs, Gergely
    Homolya, Laszlo
    Orban, Tamas I.
    Telbisz, Agnes
    Jani, Marton
    Sarkadi, Balazs
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (01) : 47 - 56
  • [8] Kindla J, 2009, EXPERT OPIN DRUG MET, V5, P489, DOI [10.1517/17425250902911463 , 10.1517/17425250902911463]
  • [9] In vitro-in vivo Extrapolation of Transporter-mediated Clearance in the Liver and Kidney
    Kusuhara, Hiroyuki
    Sugiyama, Yuichi
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2009, 24 (01) : 37 - 52
  • [10] Drug-drug interactions involving membrane transporters in the human kidney
    Li, Meng
    Anderson, Gail D.
    Wang, Joanne
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (04) : 505 - 532
12